The global vials market size was valued at USD 14.57 billion in 2025 and is projected to grow from USD 15.93 billion in 2026 to USD 35.47 billion by 2035, at a CAGR of 9.3% from 2026 to 2035.
Vials are essential primary containers for injectable pharmaceuticals, biologics, vaccines, diagnostics, and other healthcare products. Glass, particularly Type I borosilicate, remains widely used because of its chemical durability and stability, while polymer and hybrid formats offer advantages such as lower weight and improved break resistance.
The market is moving toward high-performance packaging, with greater emphasis on container-closure integrity, particulate control, dimensional consistency, delamination resistance, and compatibility with sensitive and lyophilized formulations. Ready-to-use (RTU) vials are gaining traction because they arrive pre-washed and sterilized, reducing handling and preparation requirements.
Growing demand for biologics, vaccines, peptides, and antibody-drug conjugates is also driving specialty vial development. Suppliers are increasingly differentiating through advanced glass formulations, coatings, surface treatments, inspection technologies, RTU processing, and customized packaging solutions.
Artificial intelligence (AI) is reshaping the market by fuelling automated quality control and predicting manufacturing lines with precision supply chains for glass and polymer vials. Furthermore, machine learning and digital twin models simulate and optimize vial-filling line engineering, minimizing setup times and mechanical stressors.
| Report Coverage | Details |
| Market Size in 2026 | USD 15.93 Billion |
| Market Size by 2035 | USD 35.47 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 9.3% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | By Preparation ,By Application, By End use, By Region |
| Market Analysis (Terms Used) | Value (USD Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Amcor, Arab Pharmaceutical Glass, Corning Incorporated, Daikyo Seiko, DWK Life Sciences, Gerresheimer AG, KISHORE GROUP, Mitsubishi Gas Chemical Company, Nipro, Pacific Vial Manufacturing, SCHOTT Pharma (SCHOTT Group), SGD Pharma, Shandong Province Medicinal Glass, SHIOTANI GLASS, Stevanato Group, West Pharmaceutical Services, Wuxi NEST Biotechnology |
The growing use of injectable biologics, including monoclonal antibodies, vaccines, peptides, recombinant proteins, and ADCs, is increasing demand for specialized vials. These therapies often require enhanced protection against light, temperature, surface interactions, and formulation instability. This is encouraging adoption of specialty glass, coatings, amber vials, and lyophilization-compatible designs, increasing the technical value of vial packaging.
Pharmaceutical vials must meet rigorous requirements for sterility, dimensional accuracy, chemical compatibility, particulate control, surface quality, and container-closure integrity. New materials, coatings, or designs may require extensive qualification before adoption. These requirements increase manufacturing investment, validation costs, and entry barriers, while RTU formats can also carry higher unit costs than conventional bulk vials.
Ready-to-use (RTU) vials offer manufacturers and CDMOs pre-washed, sterilized, and controlled packaging that reduces internal vial-preparation requirements. Demand is particularly promising for biologics, clinical trials, personalized medicines, and smaller production batches. Suppliers can capture additional value by offering integrated solutions such as sterile packaging systems, nests and tubs, closures, inspection, analytical services, and technical support.
Why did the ready-to-use (RTU) segment dominate the global vials market?
The ready-to-use (RTU) segment dominated the market with the largest share in 2025. The dominance of the segment can be attributed to the increasing need for contamination- and temperature-sensitive biologics and vaccines. In addition, high-purity RTU formats reduce particulate risks and chemical interactions by protecting complex drug stability.
How did the ready-to-sterilize (RTS) segment expected to hold the significantly growing global vials market in the coming years?
The ready-to-sterilize (RTS) segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be credited to the increasing adoption of sensitive biologics and a rise in demand to reduce overall contamination risks. Also, this format offers pre-validated cleanliness and lowers the probability of costly batch rejections, saving time and energy.
Why did the biologics segment dominate the global vials market?
The biologics segment dominated the market with the largest share in 2025. The dominance of the segment can be linked to the surge in use of biologic treatments for chronic diseases like autoimmune disorders across the globe. Growing adoption of pre-sterilized and nested vials that optimise filling operations and reduce particulate contamination risks for drug makers can fuel segment growth further.
How did the small molecules segment expected to hold the significantly growing global vials market in the coming years?
The small molecules segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be driven by a surge in the prevalence of cardiovascular illnesses, cancer, and other metabolic disorders, which need regular therapy. Additionally, these molecules exhibit higher chemical stability as compared to complex biologics and ensure compatibility with standard borosilicate glass.
Why did the pharma & biotech companies segment dominate the global vials market?
The pharma & biotech companies segment dominated the market with the largest share in 2025. The dominance of the segment is due to the rising need for high-grade packaging solutions that ensure the stability and safety of various drug types. Furthermore, growth by major market players such as SCHOTT AG, Gerresheimer AG, and Stevanato Group can secure steady local supply chain operations.
How did the diagnostic laboratories segment expected to hold the significantly growing global vials market in the coming years?
The diagnostic laboratories segment is expected to grow at the fastest CAGR over the study period. The growth of the segment is due to a surge in automated high-throughput screening and growing adoption of laboratory automation. Moreover, increasing genetic and clinical biobanking initiatives increase the demand for vacuum-sealed and specialized cryogenic containers.
Why did the North American region account for the largest share of the global vials market?
North America dominated the market with the largest share in 2025. The dominance of the region can be attributed to the strong presence of the biopharmaceutical sector and increasing demand for vaccines, biologics, and personalized medicine. In addition, FDA guidelines concerning sterility, container closure integrity, and chemical inertness impel drug makers to use high-grade Type I borosilicate glass.
U.S. Global Vials Market Trends
The growth of the market in the country can be driven by the increasing investment in drug development and increasing use of personalized medicine and biologics. Also, the transition towards ready-to-use (RTU) and ready-to-fill (RTF) pre-sterilized vials minimizes filling line contamination risks and preparation time for healthcare providers.
Why did the Asia-Pacific region become the fastest-growing global vials market during the forecast period?
Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The growth of the region can be credited to an increase in biologics and vaccine production and expanding pharmaceutical production hubs in emerging economies such as China and India. Furthermore, major international packaging suppliers are localizing manufacturing plants inside APAC to minimize transit friction and meet regional needs.
China Global Vials Market Trends
The market in the country is growing due to the increasing domestic healthcare expenditure and extensive presence of domestic pharmaceutical production scale. Moreover, local market players actively adopt innovative digital filling lines and stringent tamper-evident closing systems to comply with international quality standards.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has vials market.
By Preparation
By Application
By End use
By Region
Vials Market
Download Sample
Request Customization
Request Customization
Download Sample